Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Woodland Hills Pharmacy Offers 100% Pure Cholestyramine - Recommended by Experts for Treating CIRS, Mold Toxicity
  • USA - English


News provided by

Woodland Hills Pharmacy

Jul 28, 2019, 18:00 ET

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, July 28, 2019 /PRNewswire-PRWeb/ -- Doctors are increasingly choosing to treat their patients with 100% pure cholestyramine instead of using commercially available products. This is due to chronically ill patients sometimes experiencing sensitivities to inactive ingredients in the manufactured product. Woodland Hills Pharmacy is offering pure cholestyramine in multiple strengths and can ship to most states.

LOS ANGELES (PRWEB) July 28, 2019 -- Woodland Hills Pharmacy is one of the leading providers of pure cholestyramine resin in the United States. A compounding pharmacy can provide cholestyramine in its pure form without fillers, additives, and flavorings that may cause reactions in certain patients. Prescribers throughout the country are increasingly treating patients for mold-related illness with this medication. Cholestyramine has been available commercially for many years. However it is only recently that doctors treating environmentally acquired illness realized that fillers and additives could be affecting their chronically ill patients. Now, with the services of a compounding pharmacy, 100% pure cholestyramine resin can be prescribed and used by patients affected by mold toxicity.

Cholestyramine is a bile acid sequestrant that was developed in the 1950s and was first used to lower cholesterol to reduce the risk of heart disease and atherosclerosis (clogged arteries). It was also used to relieve the itching of primary biliary cirrhosis (liver disease) associated with high levels of circulating bile acids. With the advent of cholesterol-lowering statin drugs, cholestyramine was no longer prescribed as much for managing cholesterol levels and instead was used mainly for treating diarrhea. More recently it has become a primary treatment for patients suffering from chronic inflammatory response syndrome (CIRS) related to mold exposure, Lyme disease, and other conditions.

One benefit of cholestyramine is that it can minimize the need for systemic antibiotic use. Cholestyramine is not absorbed and metabolized like typical drugs. It enters the digestive system and binds to toxins in bile acid to form a complex. Then, the cholestyramine and the toxins are expelled naturally together. This prevents the reabsorption and continued enterohepatic circulation of toxins through bile acid that contributes to chronic fatigue symptoms.

The effectiveness of cholestyramine for treating toxicity after mold exposure is acknowledged by well-known doctors and researchers who are focused on treating environmentally acquired illnesses. Dr. Ritchie Shoemaker, a prominent researcher in this field, developed a protocol that involves the use of cholestyramine as a primary step in treatment after remediation of the patient's environment. Dr. Neil Nathan, who recently published the book Toxic, which is quickly becoming standard reference material for practitioners, recommends the use of pure cholestyramine for most patients.

The commercially available versions of cholestyramine are made with sweeteners, colorings, fillers, and other ingredients that are considered "inactive." While these ingredients do not affect everyone, they can cause side effects for patients with sensitivities or allergies. Patients being treated for toxicity after mold exposure often report greater sensitivities to inactive ingredients. Here is an example of the inactive ingredients found in a commercially available cholestyramine product: "acacia, citric acid, D&C Yellow No. 10, FD&C Yellow No. 6, flavor (natural and artificial Orange), polysorbate 80, propylene glycol alginate and sucrose." In comparison, Woodland Hills Pharmacy makes 100% pure cholestyramine resin with no other ingredients. This is the treatment preferred by most practitioners treating CIRS related to mold exposure.

Steve Levin, RPh, owner and pharmacist-in-charge at Woodland Hills Pharmacy, says, "Our pharmacy has been providing 100% pure cholestyramine since we opened in 2012, and the demand for this product has been consistent since then. While some treatments for treating mold toxicity can become "fads" that are quickly given up and replaced by new ones, cholestyramine has remained a core medication in almost every treatment protocol."

Woodland Hills Pharmacy offers 100% pure cholestyramine in any amount needed. The most common amounts required for a monthly supply are 150 grams, 240 grams, 360 grams, and 480 grams, but this will vary depending on the directions. A prescription is required to get pure cholestyramine. You can speak with a pharmacist at Woodland Hills Pharmacy by calling (855) 876-3060. You can also visit https://www.woodlandhillspharmacy.com for more information.

About Woodland Hills Pharmacy
Woodland Hills Pharmacy is a UCAP accredited pharmacy near Los Angeles, California. They provide high-quality compounded medications for a variety of specialties including dermatology, otolaryngology, dentistry, naturopathy, and more.

SOURCE Woodland Hills Pharmacy

Related Links

https://www.woodlandhillspharmacy.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.